Diabetes and COVID-19

 View Only
  • 1.  Diabetes management in COVID-19 patients

    Posted 03-29-2020 22:12
    Dear colleague,

    I am writing to ask for your thoughts about whether there are any specific issues related to managing diabetes in hospitalized patients with COVID-19. Are you doing anything different from usual care (SC basal-bolus insulin for non-ICU and insulin drip for ICU patients)? Do you have experience and advice for managing COVID/DM patients on high-dose steroids?

    Best regards,

    Daniel J. Rubin, MD, MSc, FACE
    Associate Professor of Medicine
    Director of Clinical Research
    Section of Endocrinology, Diabetes, and Metabolism
    Lewis Katz School of Medicine at Temple University
    Chair, Glycemic Control Taskforce, Temple University Hospital
    Communications Director, Health Care Delivery & Quality Improvement Interest Group

  • 2.  RE: Diabetes management in COVID-19 patients

    Posted 03-30-2020 13:49
    Edited by Paulina Cruz Bravo 03-30-2020 13:51
    We are starting to see patients here at Barnes-Jewish Hospital. The nurses have expressed discomfort going in every hour to do POC BG for insulin infusions. We are considering NPH q12 hours and adapting our sliding scales. We would then use the TDD from the slide to dose NPH the next day. Very curious to see what others are doing. Thanks for starting this discussion.


    Paulina Cruz Bravo, MD (she/her/hers)

    Assistant Professor of Medicine

    Division of Endocrinology, Metabolism and Lipid Research

    Washington University School of Medicine

    St. Louis, MO 


  • 3.  RE: Diabetes management in COVID-19 patients

    Posted 03-30-2020 14:54
    Prudence suggests patients be fitted with a continuous glucose monitor such as Dexcom G6 which may be remotely monitored see e.g., https://www.glooko.com/landing/dexcom/?fbclid=IwAR0aiHotf5kHSQFzEF2f0RbB-uEecUyDDu8SJnfeCKs7xwrSTDKVYje7isw

    Thomas Linn MSC

  • 4.  RE: Diabetes management in COVID-19 patients

    Posted 04-01-2020 16:15
    I do not want to be argumentative but there are many clinicians who use this site and I am not sure that prudence dictates use of CGM in the hospital setting.  Prudence can also mean to proceed with caution and there is at least anecdotal evidence that these devices do not in fact always provide accurate readings - particularly with exposure to electrocautery or imaging procedures including Xrays which are often done frequently in patients who are critically ill.  As a practical matter, this would require replacing sensing devices more frequently than needs to be done in the outpatient setting and then there is a lag time of several hours before accurate data can be obtained.  There is much discussion and some guidance on this point in the Clinical Centers Discussion Group forum.  There is at least one site that may in fact have data that will provide more guidance in the near future. So at this point CGM is not the answer to the concerns that have been raised, although several institutions including our own have policies in place that allow pts to use their own CGM devices if certain qualifications are met.

    Mary Korytkowski MD, MN, BSN

  • 5.  RE: Diabetes management in COVID-19 patients

    Posted 03-30-2020 23:08
    Dear colleague, there is no such difference regarding Diabetes management in Hospitalized patients.However ,there is no role of steroid in management of COVID 19 patients. Till now , this is my experience from indian scenario.Thanks,Asis .

  • 6.  RE: Diabetes management in COVID-19 patients

    Posted 03-31-2020 07:21
    We are interested in specifically management and risks of type 1 diabetes; this evening CET there will be a webinar ( in dutch) bij Medtronic:

    Beste zorgverlener,


    Na onze eerste zeer succesvolle webinar nodigen wij u nu graag uit voor de tweede webinar over diabetes type 1 en het COVID-19 virus op woensdag 1 april om 19.30 uur.

    Deze webinar is voor iedereen die geïnteresseerd is in diabetes type 1 en het COVID-19 virus.


    Deze webinar zal in het teken staan van diabetes type 1 en ziekte. Welke handvatten kunt u als zorgverlener aan patiënten met diabetes type 1 geven en hoe zorgen we er voor dat de diabeteszorg in deze tijd gecontinueerd wordt.


    Samen met de volgende organisaties: het Diabetesfonds, de JDRF en Diabeter hebben wij deze webinar voorbereid.

    Voor het beantwoorden van de vele vragen zullen naast de zorgverleners van Diabeter, M. Bizino internist uit het Groene Hart Ziekenhuis en I. Bosch physician assistant van de kinderkliniek Almere aan de webinar deelnemen.  


    Kijk voor meer details over de webinar op Facebook en stel een herinnering in.


    Bekijk de webinar

    Datum: Woensdag 1 april

    Tijd: 19.30 uur


    Tevens ontvangt u de link van de webinar van vorige week:

    de eerste aflevering 'Corona en diabetes type 1' van 25 maart



    Met vriendelijke groeten,



    Team Medtronic

    Bj potter van Loon

  • 7.  RE: Diabetes management in COVID-19 patients

    Posted 04-03-2020 16:39
    ​Good afternoon, everybody.

    Our hospital is preparing for a COVID surge in the coming weeks.  My CDE mentioned that some institutions that are currently inundated with patients are using glucometers that are not approved for inpatient use.  The goal of having a glucometer dedicated to each room that requires POC glucose monitoring seems reasonable.  It seems like we would be more likely to obtain outpatient glucometers than the inpatient devices on short notice.  Can anyone in an epicenter describe if this is current procedure?

    I have read the suggestion for inpatient CGM.  This does not seem feasible at this point, and the data are not available regarding accuracy in ill patients.

    Thank you!
    Mark Wilson, MD
    Santa Barbara

    Mark Wilson BA, DMSC

  • 8.  RE: Diabetes management in COVID-19 patients

    Posted 04-04-2020 13:38
    Helo  Mark,
    I agree that any glucometer for in patient use is better than no glucometer, so if you can put your hands on out-patient equipment but not something approved for hospital use, then I would certainly recommend this approach.

    As for CGM, I don't see why the accuracy of the sensor is dependent on the root cause of the glycemic level. The sensor only reacts to glucose molecules in the body. If the blood sugar level is high because of under dosing insulin, hormone increases after infection or any other reason, the sensor will still detect the glucose in the same way.  Having a CGM will make it much easier to provide intensive insulin therapy in order to reduce hyperglycemia and allow the body's normal defense mechanisms to operate more effectively.

    Note that I am not a clinician, but an engineer in the Diabetes Tech industry.

    Tom Bishop
    CTO, PKvitality SAS

    Tom Bishop
    Danvers MA

  • 9.  RE: Diabetes management in COVID-19 patients

    Posted 04-06-2020 15:52
    Edited by Anna Barash 04-06-2020 15:53

    Hi Dr. Wilson!

    What a small world! Hope you and the Santa Barbara team are well as you prepare. You and the CDE that you work with have valid concerns, and CGM would be difficult to implement on a large scale at this point. Though hopefully your hospital policy does allow people with personal CGMs to continue using them while inpatient. That will be helpful at least, for patients that come in with their own.

    We use glucometers approved for multi-patient use at our outpatient clinical research center. The ones we use are approved for both capillary and venous sampling. This may be really helpful in an inpatient setting, because you would have the ability to confirm any outlier readings with the same meter while waiting for an official reading to come back from the lab. I have been purchasing these meters for our facility, so feel free to message me if you want more information. Overall they have been affordable, and may be a good option for those patients that you have in isolation.


    Anna Barash RN CDE

    Anna Barash RN BSN CDE
    Clinical Research Nurse
    Certified Diabetes Educator
    Benaroya Research Institute
    Seattle, WA